key: cord-0322979-xtdtwdi3
authors: Hoch, Matti; Ehlers, Luise; Bannert, Karen; Stanke, Christina; Brauer, David; Caton, Vanessa; Lamprecht, Georg; Wolkenhauer, Olaf; Jaster, Robert; Wolfien, Markus
title: In silico Investigation of Molecular Networks Linking Gastrointestinal Diseases, Malnutrition, and Sarcopenia
date: 2022-03-26
journal: bioRxiv
DOI: 10.1101/2022.03.23.485443
sha: ebd5e1ab03a4804de5703af0a01ca715b0356a6e
doc_id: 322979
cord_uid: xtdtwdi3

Malnutrition is a common primary or secondary complication in gastrointestinal diseases. The patient’s nutritional status also influences muscle mass and function, which can be impaired up to the degree of sarcopenia. The molecular interactions in diseases leading to sarcopenia are complex and multifaceted, affecting muscle physiology, the intestine (nutrition), and the liver at different levels. Although extensive knowledge of individual molecular factors is available, their regulatory interplay is not yet fully understood. A comprehensive overall picture of pathological mechanisms and resulting phenotypes is lacking. In silico approaches that convert existing knowledge into computationally readable formats can help to unravel such complex systems. We compiled available experimental evidence for molecular interactions involved in the development of sarcopenia into a knowledge base, referred to as the Sarcopenia Map. By including specific diseases, namely liver cirrhosis, and intestinal dysfunction, and considering their effects on nutritional status and blood secretome, we investigated their contribution to the development of sarcopenia. The Sarcopenia Map is publicly available as an open-source, interactive online resource, providing tools that allow users to explore the information on the map and perform in silico perturbation experiments.

Malnutrition (MN) is a common and characteristic feature of gastrointestinal diseases, such as liver cirrhosis (LC) and intestinal dysfunctions (ID), e.g. short bowel syndrome (SBS), and is connected to high mortality rates 1 . For LC patients, the prevalence of MN is indicated with up to 90% 2 ; for patients suffering from SBS with around 10 to 40% 3 . Disease-related MN is closely related to mild, chronic inflammation 4 . Both MN and inflammation contribute to muscle wasting, which, combined with the loss of muscle function (sarcopenia), can negatively influence gastrointestinal diseases. Therefore, sarcopenia is a common secondary phenomenon in LC and ID. The vicious cycle of MN, inflammation, sarcopenia, and the underlying disease itself leads to an unfavorable prognosis for the patient 5 . The molecular landscape of gastrointestinal disease, nutrition, and muscle metabolism each involves hundreds to thousands of molecules and proteins that form complex molecular communication networks [6] [7] [8] . Linking these processes again increases the complexity many times over. Although the role of many molecules has been elucidated by extensive in vitro and in vivo experiments, understanding the system as a whole, including all the interactions involved, is a task beyond human capabilities. Therefore, the use of in silico approaches, i.e., the conversion of available knowledge into computationally readable formats, can help unravel its complex structure.

Disease maps have emerged as web-based knowledge bases summarizing information about molecular interactions in standardized graph representations enabling disease-specific interactive visualizations and in silico experiments 9 . Examples of disease maps include the Atlas of Inflammation Resolution (AIR) 10 , the Parkinson's Disease Map 11 , the Rheumatoid Arthritis Map 12 , the AsthmaMap 13 , the Atherosclerosis Map 14 , or the COVID-19 disease map 15 . Many of those have been published on MINERVA, a web platform that provides interactive visualizations of standardized molecular knowledge graphs 16 . MINERVA provides automatic annotation, linkage of molecules to external databases, and screening for associated miRNAs, drugs, or chemicals in the graph. In addition, MINERVA allows the development of tools that interact with the map components, making it an excellent framework for web-based disease map presentations. The use of standards such as the systems biology markup language (SBML) 17, 18 ensures reproducibility, and allows the development of general-purpose tools and automatic annotation, following FAIR principles for scientific data 19 . By modularizing the interactions into cell type-, tissue-, or process-specific parts, i.e., creating so-called submaps, 4 disease maps help to provide an intuitive overview of complex disease mechanisms. These submaps can further be enriched with regulatory interactions from transcription factors, microRNAs (miRNAs) and lncRNAs, or even drugs and chemicals, providing a comprehensive, large-scale molecular interaction map (MIM) 10 . The MIM itself is a directed graph encompassing all interactions that connect the elements, i.e., biological entities in the graph, through activating (positive) or inactivating (negative) causal links. Although the information in disease maps is standardized, the process of creating disease maps, their analysis, and the ultimate search for information is not predetermined and depends mainly on the context, style, and research question.

Topological analyses trace causal interactions throughout the network and track the occurrence of nodes 20, 21 . This allows to identify relationships between distant elements, identify hub elements in pathways or provide a weighting of elements regulating a specific phenotype 22 .

Topological methods have also been used to extract core regulatory networks from large-scale networks to investigate mechanisms on a smaller scale 23 . In addition, topological information has been used to improve the analytical performance of statistical enrichment 24 or machine learning approaches 25 . Topological analysis is less complex but can be problematic in highly interconnected networks. Identifying all paths in larger networks, i.e., all connections between every pair of elements, is a computationally intensive challenge. Consequently, many algorithms focus on identifying only the shortest paths between two nodes in the graph 26 . Moreover, topological analysis can be highly affected by biases such as (i) misestimating the length of interactions that lack intermediates, (ii) neglecting the biochemical relevance of longer pathways, and (iii) overrepresenting more intensively studied molecules. Nevertheless, they provide a middle ground between ease of implementation and informative power to compare which elements are included in a given pathway and to what extent.

Boolean models are much better suited to study actual network mechanisms and to investigate the effects of molecular perturbations. In Boolean models, the state of each gene/molecule/phenotype is constrained to be either active (ON/1) or inactive (OFF/0), defined by specific Boolean rules based on the state of other network elements 27 . In successive steps, representing a time scale, the state of each element in the map is evaluated based on states during the previous step. Since there is a finite number of possible network states, at some point a steady state is reached that is either stable, i.e., remains in one state, or oscillates, i.e., changes infinitely often between several states. The steady state provides useful qualitative information on molecular mechanisms, in particular on circulating regulatory feedback and 5 feedforward loops. Analysis of the number of active states as a function of a given input makes it possible to determine correlations between elements regardless of their distance in the network 28, 29 . This is of great importance in complex processes such as energy metabolism, where the influence of each nutrient must be considered equally at each time point. Moreover, in Boolean models, the computational time increases only proportionally to the complexity of the network, allowing efficient high-throughput analyses. Recently, Montagud et al. created personalized Boolean models from clinical data of cancer patients to predict drug targets and validated their results with cell line-specific models 30 . The development of a Boolean model simulating the influence of nutrition and metabolism on sarcopenia may therefore prove useful in assessing the effects of various physiological and pathological conditions.

We developed an in-depth, standardized, and computationally encoded disease map of the molecular regulatory environment that regulates sarcopenia. We integrated the two disease states, ID and LC, into the map by describing their impact on nutritional and sarcopenic molecular processes. We modularized the map into tissue-specific sub-maps for i) the intestine, i.e., nutrient uptake, its hormonal regulation, and the effects of ID, ii) the liver, i.e., metabolic processes, cytokine secretion, and their alteration in LC, iii) and the muscle, i.e., molecular regulation of catabolic and anabolic muscular processes leading to sarcopenia. In addition, we converted the underlying interaction network into a Boolean model and validated the model by investigating how molecular perturbations are perpetuated in the model. We integrated our methods into an interactive MINERVA tool suite allowing researchers to explore the information on the maps, identify interaction pathways, and perform in silico perturbation experiments. With these tools, we demonstrate how the map contributes to understanding the complex molecular processes leading to sarcopenia.

We screened the PubMed database for published literature focusing on reviews describing the intestinal uptake of nutrients and their metabolism in the liver, hormonal communication between liver and muscle, and regulation of muscle growth and function. Simultaneously, we sought information on the effects of ID and LC on these processes. We collected the information in three Systems Biology Markup Language (SBML)-standardized submaps in CellDesigner 18, 31 . To improve clarity and ease curation efforts. Intracellular molecules were enclosed in 6 compartments reflecting the organ while extracellular molecules were placed outside the compartments, either representing molecules in the bloodstream (e.g., nutrients or cytokines) or systemic conditions, such as acidosis or hyperammonemia. This separation enables the distinction between tissue-specific processes and connects them through the intervening communication processes. Figure 1A provides a schematic overview of the map organization ad the hierarchical flow of information through the submaps.

Different shapes and colors enable intuitive visualizations for various biological or clinical entities, including (i) molecules, such as genes, proteins, or metabolites; (ii) their subclasses, such as receptors and ion channels; (iii) clinical features; (iv) whole pathways. All these entities we collectively refer to as map elements ( Figure 1B) . We connected the elements by SBMLstandardized reactions representing their biochemical interaction. We simplified most reactions in the activity flow format, i.e., represented more complex mechanisms (e.g., phosphorylations) as single arrows connecting a source element (e.g., the protein kinase) with a target element (e.g., the protein). This simplification reduces the map content and improves readability while retaining all necessary information. Only enzymatic reactions were retained in the process description format because information about enzymes is necessary for modeling the mechanisms of metabolic regulations. Larger metabolic pathways, e.g., glycolysis, have been combined into a single catalytic reaction leading from the initial reactant (glucose) to the final product (pyruvate), omitting all intermediates. The reaction is catalyzed by a phenotypic element (glycolysis) that represents the metabolic pathway per se. All regulations, e.g., productfeedback-inhibitions or hormonal, were then added as reactions to the phenotype element (exemplarily shown in Figure 1B ). 

We transformed the maps into a single graph (G) consisting of a set of elements (vertices ሺ ሻ ) connected by interactions (edges ሺ ሻ 

We identified paths in the MIM using a breadth-first-search (BFS) algorithm, one of the fastest possible solutions in a directed and unweighted graph 32 Figure 1C ). This separation of paths provides us with information on i) the ratio of positive and negative paths between s and t, which e is involved in, and ii) the ratio of how e is regulated by s and how e regulates t. Repeating this analysis for other elements in the MIM compares their role in the investigated pathway.

Based on the interactions in the submaps, we defined a Boolean rule for each element that specifies how its state (either ON or OFF) is defined by the state of other elements (inputs)

represented by logical gates (NOT, OR, or AND). A Boolean rule may consist of multiple gates, which may be nested. When a reaction requires multiple elements to be active, such as in enzymatic reactions or the formation of complexes, these elements are represented by AND gates. Any negative input, such as from a disease or negative feedback, is integrated as a NOT gate. In general, all logic gates must be satisfied for an element to be ON, with disease inputs taking precedence. An exception, however, is the glycogen element in the model, whose state we represent as an integer that increases by 1 at each step at which the element's Boolean rule 9 is satisfied and decreases by 1 when it is not. As long as its state is greater than zero, it is treated as an ON input to other elements. In this way, we can simulate the construction of a storage and its subsequent use, even after its inputs subsided. Finally, we defined an initial state of the model in which some elements with no inputs, such as digestive enzymes or transporters, are set to ON. Supplementary File 1 shows the list of map elements with their initial state.

We identified the correlations between two elements based on the dependency of their activity.

The principle behind this methodology has been described by Helikar 

The phenotypes 'anabolism' and 'catabolism' themselves are defined as:

The perturbation experiment was then repeated for different activities of s. Finally, the correlation between both elements was analyzed using the 'pearsonr' function from the stats module of the scipy python package generating the Pearson correlation coefficient and a twosided p-value.

We present the Sarcopenia Map as a publicly available, comprehensive knowledge base of experimental evidence for molecular interactions underlying sarcopenia, linking it to ID and LC 

We have compiled findings from the scientific literature into three standardized, tissue-specific submaps ( Figure 2A ). The submaps summarize the processes in each tissue as SBML- Figure 2B shows the distribution of elements between submaps. Their overlap is more dominant for extracellular elements, which is to be expected since they represent secreted molecules that communicate between compartments. The highest number of tissue unique elements is found in the submap of the intestine, as it contains food components as well as digestive enzymes and transporters.

MINERVA provides features to explore elements in the map and targets of specific drugs, miRNAs, or chemicals. The submaps are publicly accessible and can be downloaded in annotated with references to public databases or scientific literature (e.g., PubMed). The Sarcopenia Map comes with an interactive tool that we developed to allow users to explore interaction paths in the sarcopenia map through topological analysis and to perform in silico simulations with the Boolean model in an easy-to-use interface ( Figure 2C ). 

The first part of the map tool provides network topology analyses to investigate, which elements are included in filtered interaction pathways between specific elements to explore their underlying molecular regulatory mechanisms. It provides an overview of the elements included in filtered interaction paths between specific elements to explore their underlying molecular regulatory mechanisms. Users select a source element ("From") and a target element ("To") whose interaction paths are to be identified in the MIM ( Figure 3A ). In addition, another element can be specified to show only the interactions that pass "Through" that element. The output will be a table that shows all identified paths, their length, the total impact on the target, and the individual steps within the path, including their interactions ( Figure 3B ). In addition, a bar chart lists the percentage of these paths, in which each element occurs, separated into positive and negative paths ( Figure 3C ). However, due to the limitations of topological models, assumptions about functional relationships should not be inferred from the distribution of positive and negative interaction paths alone. Nevertheless, they provide an intuitive overview of the design of molecular pathways and the flow of information.

13 In addition to topological analysis, we created a Boolean model of the sarcopenia map and integrated functions into the map tool to observe individual steps as colored overlays on the maps, identify stable states, and analyze correlations between elements. Supplementary Figure   4 illustrates the activity of elements during the oscillating steady state, which evolves from the default input state of the map and simulates permanently active food input. It can be seen that most of the elements that change state during steady state are metabolites and metabolic enzymes. Feedback loops of metabolic pathways are responsible for this behavior, as shown by the example of glucose metabolism in the liver. As food intake is constantly ON, so is extracellular glucose, leading to a constant oscillation between glycolysis and glycogen synthesis. Feedback loops are essential for reversible reactions in Boolean models because without them, the ON signal would be constantly active in both elements, even if the external 14 signal was OFF. Once we set the food intake to OFF and iterate forward, the new resulting steady state is stable, i.e., it does not fluctuate and has no active metabolites (not shown).

The tool also enables the identification of correlations between elements in the map based on a user-defined state of the model. For a selected source element, its activity is iteratively changed from 0 to 1 in 0.05 increments, and for each, the activity of all other elements is measured for 100 steps. A resulting table presents the Pearson correlation coefficient for all elements and also shows the activity correlation plot. However, in Boolean models, it is difficult to keep track and rank the elements that have transmitted signals throughout the network, since their execution involves hundreds of steps with multiple feedback loops throughout the network.

To find a feasible solution for this problem, our tool ranks all elements in the network according to their correlation with the source and destination elements. Elements that correlate with both simultaneously are most likely responsible for transmitting the signals. In addition, based on the type of correlation (positive or negative), we can investigate the role of the transmitting element,

i.e., whether inhibition/activation of an inhibitory/activating signal has occurred or vice versa.

To validate the Boolean model, we studied the behavior of the carbohydrate system under different nutrient conditions, i.e., activities of the food intake element. Since carbohydrate metabolism is a tightly regulated system and the central part of the energy cycle that controls muscle function, we need to ensure that in our model carbohydrate levels respond to perturbations similarly to physiological conditions. We tested the model by measuring the response of glucose and glycogen to altered nutritional stimuli. Figure 4A shows the extent of hepatic glycogen storage (blue dots) in response to an increasingly number of steps with an active food intake (y-axis, black dots). As expected, an increased value of hepatic glycogen and an increasingly prolonged decrease after reaching the maximum value were observed when food intake is switched off. In addition, blood glucose (red dots) is continuously active as long as food intake occurs and is oscillating during glycogen depletion. These results show that our model can simulate the conversion of glycogen to glucose and its release into the bloodstream in fasting situations.

Next, we measured carbohydrate behavior again, but with different combinations of ON and OFF food intake, representing changing frequency and quantity, but not quality, of diet.

From these, we identified three specific nutrition states which will act as input for the model to simulate (patho-)physiological behavior. In Figure 4B we show the carbohydrate behavior of the selected nutrition states: (i) undernourished, i.e., long fasting periods with full depletion of glycogen storage between food intake, (ii) well-nourished, with continuous glycogen storage, and (iii) overnourished, with continuously increasing glycogen. The carbohydrate metabolism is a key pathway in connecting gastrointestinal disease with sarcopenia. In clinical settings, glucose supplementation has been shown to reduce muscle mass loss, while glycogen depletion in LC patients has been identified as a major cause of the development of sarcopenia 33, 34 . Therefore, we investigated how a deficiency in glycogen reserves impacts glucose substitution and muscle phenotypes under the selected nutrition states ( Figure 4C ) Next, we investigated the correlations between activities of LC and ID on the muscle phenotypes 'anabolism', 'catabolism', and 'sarcopenia' dependent on the nutritional state ( Figure 5 ). In both diseases, we see a strong positive correlation with catabolism (blue) and a negative correlation with anabolism (red). Thus, both disease states also correlate positively with sarcopenia. No significant differences are seen between the nutritional states. However, we see a lower contribution of both diseases to anabolism in the undernourished state compared to the other states. Presumably, this is due to the generally lower activity of anabolism in the undernourished state. In general, the correlation tends to be constant in the overnourished state, whereas the correlations diverge more in the nourished and undernourished states. In these two groups, we see a strong increase in catabolism and sarcopenia activity at low LC activities. This may suggest that in malnourished states, even a low LC disease severity has a large effect on muscle phenotypes. In ID, phenotypes show an almost plateau-like behavior at low disease activities (<0.5) and only then start to increase. This is to be expected because at low frequencies of food intake, the effects of the lower activities of ID, which are mainly related to food resorption, are minimal. 

The Sarcopenia Map is available as an open-source resource at https://www.sbi.unirostock.de/minerva/index.xhtml?id=SarcopeniaMap

The authors declare no competing financial or non-financial interest.

Systematic review with meta-analysis: Nutritional screening and assessment tools in cirrhosis

A Systematic Review of Medical Nutrition Therapy Guidelines for Liver Cirrhosis: Do We Agree?

Short-Bowel Syndrome: Epidemiology, Hospitalization Trends, In-Hospital Mortality, and Healthcare Utilization

Disease-Related Malnutrition and Sarcopenia as Determinants of Clinical Outcome

Preclinical insights into the gut-skeletal muscle axis in chronic gastrointestinal diseases

The unmapped chemical complexity of our diet

The gut-liver axis and the intersection with the microbiome

Exercise Metabolism and the Molecular Regulation of Skeletal Muscle Adaptation

Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms

The Atlas of Inflammation Resolution (AIR)

Integrating Pathways of Parkinson's Disease in a Molecular Interaction Map

Computational Systems Biology Approach for the Study of Rheumatoid Arthritis: From a Molecular Map to a Dynamical Model

AsthmaMap: An expert-driven computational representation of disease 21 mechanisms

New models of atherosclerosis and multi-drug therapeutic interventions

COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms

MINERVA-a platform for visualization and curation of molecular interaction networks

The systems biology markup language (SBML): A medium for representation and exchange of biochemical network models

<scp>SBML</scp> Level 3: an extensible format for the exchange and reuse of biological models

The FAIR Guiding Principles for scientific data management and stewardship

A Guide to Conquer the Biological Network Era Using Graph Theory. Front

Biological function through network topology: a survey of the human diseasome

Network-and Enrichment-based Inference of Phenotypes and Targets from large-scale Disease Maps (Accepted for publication in npj

Unraveling a tumor type-specific regulatory core underlying E2F1-mediated epithelial-mesenchymal transition to predict receptor protein signatures

Gene Set Enrichment Analysis of Interaction Networks Weighted by Node Centrality

Predicting effective drug combinations using gradient tree boosting based on features extracted from drug-protein heterogeneous network

Computing paths and cycles in biological interaction graphs

Boolean modeling of biological regulatory networks: A methodology tutorial

The Cell Collective: Toward an open and collaborative approach to systems biology

ChemChains: a platform for simulation and analysis of biochemical networks aimed to laboratory scientists

Patient-specific Boolean models of signalling networks guide personalised treatments

CellDesigner: a process diagram editor for gene-regulatory and biochemical networks

A graph-traversal approach to identify influential nodes in a network

Sarcopenia in cirrhosis: A practical overview

Sarcopenia in cirrhosis: from pathogenesis to interventions

Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes

Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview